Israel - Hebrew - Ministry of Health

biovac ltd., israel - doxycycline as hydrochloride - אבקה להכנת תמיסה - doxycycline as hydrochloride 100 %

Israel - Hebrew - Ministry of Health

abic veterinary products ltd - sulfadimethoxine sodium - אבקה להכנת תמיסה - sulfadimethoxine sodium 100 %

Israel - Hebrew - Ministry of Health

abic veterinary products ltd - sulfadimethoxine sodium - אבקה להכנת תמיסה - sulfadimethoxine sodium 100 %

Israel - Hebrew - Ministry of Health

ש. שסטוביץ בע"מ - כלל האוכלוסיה - משחה המעניקה הקלה מיידית ולאורך זמן לשיניים רגישות

Israel - Hebrew - Ministry of Health

abic veterinary products ltd - sulphadiazine; trimethoprim - אבקה - sulphadiazine 250 mg/g; trimethoprim 50 mg/g

Israel - Hebrew - Ministry of Health

perrigo israel agencies ltd - כלל האוכלוסיה - gives relief of pain via mechanical barrier action by a protective film that forms in situ and adheres to the oromucosal surface. intended use of episil® includes oral mucositis that may be caused by chemotherapy or radiotherapy

Israel - Hebrew - Ministry of Health

עדי לין אול מדיק בע"מ - אחות - חלוקים, מסכות פנים, כיסויי ראש, כיסויי נעלים, כיסויי מיטות חד פעמיים לכול הצוות הרפואי

Israel - Hebrew - Ministry of Health

abic veterinary products ltd - sulfachlorpyrazine sodium monohydrate - אבקה להכנת תמיסה - sulfachlorpyrazine sodium monohydrate 47 %w/w

Israel - Hebrew - Ministry of Health

biovac ltd., israel - sulfachlorpyrazine as sodium monohydrate - אבקה להכנת תמיסה - sulfachlorpyrazine as sodium monohydrate 30 %

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - losartan potassium - טבליות מצופות פילם - losartan potassium 50 mg - losartan - losartan - hypertension: losartan is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losartan is not recommended. renal protection in type-2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrophy. the benefit of losartan on the primary deposite endpoi